Enrique Lerma

7.7k total citations
105 papers, 3.5k citations indexed

About

Enrique Lerma is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Enrique Lerma has authored 105 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 32 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Enrique Lerma's work include Cervical Cancer and HPV Research (10 papers), Breast Cancer Treatment Studies (9 papers) and BRCA gene mutations in cancer (8 papers). Enrique Lerma is often cited by papers focused on Cervical Cancer and HPV Research (10 papers), Breast Cancer Treatment Studies (9 papers) and BRCA gene mutations in cancer (8 papers). Enrique Lerma collaborates with scholars based in Spain, United States and Finland. Enrique Lerma's co-authors include Jaime Prat, Xavier Matías‐Guiu, Gloria Peiró, Daniel Escuín, Agustí Barnadas, Alberto Gallardo, Dı́dac Mauricio, Fernando Ortiz-Martínez, Carmen Alonso and Encarna Adrover and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Gastroenterology.

In The Last Decade

Enrique Lerma

103 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enrique Lerma Spain 34 1.3k 1.2k 966 643 481 105 3.5k
E. McDermott Ireland 34 1.0k 0.8× 1.2k 1.0× 1.2k 1.3× 318 0.5× 471 1.0× 94 3.0k
Aziza Nassar United States 31 709 0.5× 1.3k 1.1× 856 0.9× 676 1.1× 858 1.8× 146 3.3k
Taizo Shiraishi Japan 35 1.5k 1.2× 904 0.8× 579 0.6× 1.4k 2.2× 524 1.1× 145 3.7k
Yun Gong United States 35 1.1k 0.9× 1.9k 1.6× 1.1k 1.1× 1.0k 1.6× 432 0.9× 118 3.6k
Kenichi Ohashi Japan 29 1.3k 1.0× 796 0.7× 586 0.6× 939 1.5× 747 1.6× 300 4.1k
Thomas B. Crotty United States 29 1.1k 0.8× 553 0.5× 716 0.7× 1.4k 2.1× 782 1.6× 64 3.8k
Joseph A. Holden United States 34 1.6k 1.2× 1.3k 1.1× 647 0.7× 523 0.8× 541 1.1× 108 3.3k
Salvador J. Díaz‐Cano United Kingdom 28 716 0.6× 753 0.6× 530 0.5× 413 0.6× 505 1.0× 105 2.7k
Dongfeng Tan United States 37 1.9k 1.5× 1.6k 1.4× 897 0.9× 901 1.4× 772 1.6× 124 4.0k
Frank T. Kolligs Germany 40 2.9k 2.3× 1.6k 1.4× 809 0.8× 785 1.2× 832 1.7× 106 5.1k

Countries citing papers authored by Enrique Lerma

Since Specialization
Citations

This map shows the geographic impact of Enrique Lerma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Lerma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Lerma more than expected).

Fields of papers citing papers by Enrique Lerma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrique Lerma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Lerma. The network helps show where Enrique Lerma may publish in the future.

Co-authorship network of co-authors of Enrique Lerma

This figure shows the co-authorship network connecting the top 25 collaborators of Enrique Lerma. A scholar is included among the top collaborators of Enrique Lerma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrique Lerma. Enrique Lerma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martínez‐Barriocanal, Águeda, José Antonio Casado, Marı́a José Ramı́rez, et al.. (2020). Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer. Clinical Cancer Research. 26(12). 3044–3057. 21 indexed citations
2.
Farré, Núria, David Santos, Jari Metso, et al.. (2019). Human ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in Mice. International Journal of Molecular Sciences. 20(3). 655–655. 8 indexed citations
3.
Santos, David, Núria Farré, Sergi Leánez, et al.. (2018). Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice. PLoS ONE. 13(10). e0204841–e0204841. 8 indexed citations
4.
Perez‐Balaguer, Ariadna, et al.. (2015). FOXA2 mRNA expression is associated with relapse in patients with Triple-Negative/Basal-like breast carcinoma. Breast Cancer Research and Treatment. 153(2). 465–474. 29 indexed citations
5.
Mato, Eugènia, et al.. (2014). ABCG2/BCRP gene expression is related to epithelial–mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1). Journal of Molecular Endocrinology. 52(3). 289–300. 24 indexed citations
6.
Tibau, Ariadna, Laura López-Vilaró, Maitane Pérez-Olabarría, et al.. (2014). Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer. Neoplasia. 16(10). 861–867. 12 indexed citations
7.
Lerma, Enrique, et al.. (2013). A novel technique for craniospinal irradiation with rapid arc. Reports of Practical Oncology & Radiotherapy. 18. S127–S127. 1 indexed citations
8.
Castellana, Bárbara, Daniel Escuín, Gloria Peiró, et al.. (2012). ASPN and GJB2 Are Implicated in the Mechanisms of Invasion of Ductal Breast Carcinomas. Journal of Cancer. 3. 175–183. 66 indexed citations
9.
Peiró, Gloria, Encarna Adrover, Laura Sánchez-Tejada, et al.. (2010). Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma. Modern Pathology. 24(2). 201–208. 39 indexed citations
10.
Honrado, Emiliano, Ana Osório, Roger L. Milne, et al.. (2007). Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Modern Pathology. 20(12). 1298–1306. 41 indexed citations
11.
López‐Navidad, A, et al.. (2007). Corneal Transplantations From Donors With Cancer. Transplantation. 83(10). 1345–1350. 14 indexed citations
12.
Lerma, Enrique, et al.. (2007). Effectiveness of Liquid-Based Cytology and Papanicolaou Tests in a Low Risk Population. Acta Cytologica. 51(3). 399–406. 13 indexed citations
13.
Honrado, Emiliano, Ana Osório, Alicia Cazorla, et al.. (2005). Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Research and Treatment. 90(1). 5–14. 127 indexed citations
14.
Lerma, Enrique, et al.. (2003). Comparative Findings of Lymphocytic Thyroiditis and Thyroid Lymphoma. Acta Cytologica. 47(4). 575–580. 18 indexed citations
15.
Bolufer, Pascual, Eva Barragán, Amparo Verdeguer, et al.. (2002). Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.. PubMed. 87(1). 23–32. 8 indexed citations
16.
Martínez-Climent, José A., Miguel Ángel Seguí, Gloria Peiró, et al.. (2001). Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment. The Breast. 10(1). 67–77. 26 indexed citations
17.
Lerma, Enrique, et al.. (2000). Undetected invasive lobular carcinoma of the breast: Review of false-negative smears. Diagnostic Cytopathology. 23(5). 303–307. 12 indexed citations
18.
Solves, Pilar, Pascual Bolufer, Eva Barragán, et al.. (1999). Chronic myeloid leukemia with expression of ALL-type BCR/ABL transcript: a case-report and review of the literature. Leukemia Research. 23(9). 851–854. 5 indexed citations
19.
Lerma, Enrique, et al.. (1998). Rescreening of atypical cervicovaginal smears using PAPNET. Cancer. 84(6). 361–365. 10 indexed citations
20.
Prat, Jaime, Esther Oliva, Enrique Lerma, Manuel Vaquero, & Xavier Matías‐Guiu. (1994). Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content. Cancer. 74(6). 1778–1783. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. McDermott Breakdown of academic impact, for papers by Aziza Nassar Breakdown of academic impact, for papers by Taizo Shiraishi Breakdown of academic impact, for papers by Yun Gong Breakdown of academic impact, for papers by Kenichi Ohashi Breakdown of academic impact, for papers by Thomas B. Crotty Breakdown of academic impact, for papers by Joseph A. Holden Breakdown of academic impact, for papers by Salvador J. Díaz‐Cano Breakdown of academic impact, for papers by Dongfeng Tan Breakdown of academic impact, for papers by Frank T. Kolligs
Rankless by CCL
2026